Pamela S. Ohashi

University Health Network — Canada

Immunology and Microbiology · Life Sciences

110h-index52.3kcitations688works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(238), Cancer Immunotherapy and Biomarkers(234), T-cell and B-cell Immunology(185), Immunotherapy and Immune Responses(173), CAR-T cell therapy research(98)

Publications684 total

Supplementary Figures 1 from Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
2026Open Access
Supplementary Tables 1 from Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
2026Open Access
Data from Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
2026Open Access
Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab
npj Precision Oncology·2026Open Access
B cells drive CD4 T cell immunosenescence and age-associated health decline
Science Immunology·2026
Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research·2025Open Access
Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma
Genome Medicine·2025Open Access
Trial protocol 1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
2025Open Access
Suppl Table S2 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
2025Open Access
Suppl Figure S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
2025Open Access
Supplementary Table S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
2025Open Access
Guidelines for T cell nomenclature
Nature reviews. Immunology·2025· 11 citedOpen Access
Intratumoural CD103+CD56+ ILCs are associated a with dysfunctional CD8+ T cell profile in patients with ovarian epithelial carcinoma 4835
The Journal of Immunology·2025Open Access
Tissue-resident MAIT17 cells are associated with angiogenic pathways and tumor recurrence in non-small cell lung cancer (NSCLC) 3966
The Journal of Immunology·2025Open Access
Immunoregulatory NK cells in non small cell lung cancer (NSCLC) 3221
The Journal of Immunology·2025Open Access
Development and preclinical validation of a therapeutic γδ TCR-engineered cell product for pan-cancer targeting 3442
The Journal of Immunology·2025Open Access
Microbiome metabolites modulate MAIT cell response to immune checkpoint blockade in non-small cell lung cancer (NSCLC) 3096
The Journal of Immunology·2025Open Access
Protocol for halofuginone-mediated metabolic reprogramming of murine T cells via activation of the GCN2 pathway
STAR Protocols·2025· 2 citedOpen Access
OA12.04 Radiation Reprograms CDKN2A/p16 Wild Type Epithelioid Mesothelioma Towards an Immune Responsive Tumor Microenvironment
Journal of Thoracic Oncology·2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases
Therapeutic Advances in Medical Oncology·2025Open Access
page 1 of 35Next →

Frequent Co-authors

Andrew Wakeham(23), Tak W. Mak(16), Josef Penninger(13), Thomas M. Kündig(11), Arda Shahinian(11), Tak W. Mak(8), Martin F. Bachmann(8), Linh T. Nguyen(6), Gordon S. Duncan(6), Denis Bouchard(6), Young‐Yun Kong(5), T. Matsuyama(5), Annick Itié(5), Rudolf Schmits(5), John Simard(5), Klaus Pfeffer(4), Kenji Kishihara(4), Bernhard Odermatt(4), Takehiko Sasaki(4), Caren Furlonger(4)